Fused ring azadecalin glucocorticoid receptor modulators

A compound having the formula

• wherein
• L1 and L2 are members independently selected from a bond and unsubstituted alkylene;
• R1 is a member selected from unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted heterocycloalkyl, —OR1A, —NR1CR1D, —C(O)NR1CR1D, and —C(O)OR1A, wherein
• R1A is a member selected from hydrogen, unsubstituted alkyl and unsubstituted heteroalkyl,
• R1C and R1D are members independently selected from unsubstituted alkyl and unsubstituted heteroalkyl,
• wherein R1C and R1D are optionally joined to form an unsubstituted ring with the nitrogen to which they are attached, wherein said ring optionally comprises an additional ring nitrogen;
• R2 has the formula:
• wherein
• R2G is a member selected from hydrogen, halogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, —CN, and —CF3;
• J is phenyl;
• t is an integer from 0 to 5;
• X is —S(O2)—;
• and
• R5 is phenyl optionally substituted with 1-5 R5A groups, wherein
• R5A is a member selected from hydrogen, halogen, —OR5A1, —S(O2)NR5A2R5A3, —CN, and unsubstituted alkyl, wherein
• R5A1 is a member selected from hydrogen and unsubstituted alkyl, and
• R5A2 and R5A3 are members independently selected from hydrogen and unsubstituted alkyl.